Interaction of
Activation, Metabolic
Animals
Antimutagenic Agents
/ isolation & purification
Benzo(a)pyrene
/ metabolism
Cytochrome P-450 CYP1A1
/ antagonists & inhibitors
Cytochrome P-450 CYP1A2
/ metabolism
Cytochrome P-450 CYP1A2 Inhibitors
/ isolation & purification
Cytochrome P-450 Enzyme Inhibitors
/ isolation & purification
DNA Damage
/ drug effects
Flavonoids
/ isolation & purification
Humans
Hydrocharitaceae
/ metabolism
Isoenzymes
Kinetics
Micronuclei, Chromosome-Defective
/ chemically induced
Micronucleus Tests
Oxidative Stress
/ drug effects
Polyphenols
/ isolation & purification
Rats
Salmonella typhi
/ drug effects
CYP1A1
Thalassia testudinum
benzo[a]pyrene
chemoprevention
polyphenols
thalassiolin B
Journal
Marine drugs
ISSN: 1660-3397
Titre abrégé: Mar Drugs
Pays: Switzerland
ID NLM: 101213729
Informations de publication
Date de publication:
19 Nov 2020
19 Nov 2020
Historique:
received:
31
10
2020
revised:
15
11
2020
accepted:
17
11
2020
entrez:
24
11
2020
pubmed:
25
11
2020
medline:
19
5
2021
Statut:
epublish
Résumé
The aim of the present work was to evaluate the effects of
Identifiants
pubmed: 33227946
pii: md18110566
doi: 10.3390/md18110566
pmc: PMC7699293
pii:
doi:
Substances chimiques
Antimutagenic Agents
0
Cytochrome P-450 CYP1A2 Inhibitors
0
Cytochrome P-450 Enzyme Inhibitors
0
Flavonoids
0
Isoenzymes
0
Polyphenols
0
thalassiolin B
0
Benzo(a)pyrene
3417WMA06D
CYP1A1 protein, human
EC 1.14.14.1
CYP1A2 protein, human
EC 1.14.14.1
Cyp1a2 protein, rat
EC 1.14.14.1
Cytochrome P-450 CYP1A1
EC 1.14.14.1
Cytochrome P-450 CYP1A2
EC 1.14.14.1
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CITMA
ID : P211LH005-019
Organisme : FONDECYT
ID : 1130601
Organisme : Becas de Excelencia del Gobierno de México para Extranjeros
ID : SN
Références
Toxicol In Vitro. 2020 Feb;62:104681
pubmed: 31655123
Mutat Res. 2003 Jan;543(1):17-30
pubmed: 12510015
Int J Mol Sci. 2016 Aug 19;17(8):
pubmed: 27548149
Food Chem Toxicol. 2017 Aug;106(Pt A):165-174
pubmed: 28533128
Methods Mol Biol. 2006;320:31-7
pubmed: 16719372
Z Naturforsch C J Biosci. 2012 May-Jun;67(5-6):291-6
pubmed: 22888534
Am J Clin Nutr. 2005 Jan;81(1 Suppl):215S-217S
pubmed: 15640483
Int J Cancer. 1976 Sep 15;18(3):362-8
pubmed: 955747
Biochem Biophys Res Commun. 2003 Apr 11;303(3):902-7
pubmed: 12670496
Toxicol In Vitro. 2008 Aug;22(5):1242-9
pubmed: 18502604
Environ Toxicol Pharmacol. 2013 Nov;36(3):989-96
pubmed: 24095716
Environ Health Perspect. 1997 Jun;105 Suppl 4:945-54
pubmed: 9255586
J Pharm Bioallied Sci. 2016 Apr-Jun;8(2):83-91
pubmed: 27134458
Carcinogenesis. 2001 Mar;22(3):453-9
pubmed: 11238186
Biol Pharm Bull. 2007 Dec;30(12):2268-73
pubmed: 18057710
Arch Biochem Biophys. 1994 Aug 1;312(2):436-46
pubmed: 8037457
Biochem Pharmacol. 1994 Aug 30;48(5):923-36
pubmed: 8093105
Oxid Med Cell Longev. 2016;2016:7428515
pubmed: 27034742
Carcinogenesis. 2000 Mar;21(3):525-30
pubmed: 10688873
Mar Biotechnol (NY). 2009 Jan-Feb;11(1):74-80
pubmed: 18607659
Int J Mol Sci. 2015 Apr 24;16(5):9236-82
pubmed: 25918934
Drug Metab Pers Ther. 2015 Dec;30(4):251-6
pubmed: 26444365
Chem Res Toxicol. 2002 Feb;15(2):170-9
pubmed: 11849043
Carcinogenesis. 1998 Oct;19(10):1847-53
pubmed: 9806168
Toxicol Lett. 2015 Nov 19;239(1):1-8
pubmed: 26278343
Anal Biochem. 1979 Jun;95(2):351-8
pubmed: 36810
Cancer Res. 2006 Dec 15;66(24):11938-45
pubmed: 17178892
Life Sci. 2007 Jul 26;81(7):519-33
pubmed: 17655876
Mutat Res. 1998 May 25;400(1-2):201-13
pubmed: 9685642
Mutat Res. 1994 Jun;312(3):293-304
pubmed: 7514741
Bioorg Med Chem. 2002 Nov;10(11):3619-25
pubmed: 12213478
Mol Pharmacol. 2013 Sep;84(3):304-13
pubmed: 23761301
Carcinogenesis. 2002 Dec;23(12):1969-77
pubmed: 12507920
Mol Pain. 2011 Jan 24;7:10
pubmed: 21261973
Cancer Cell Int. 2014 Jan 23;14(1):6
pubmed: 24456610
Environ Mol Mutagen. 2005 Mar-Apr;45(2-3):106-14
pubmed: 15688365
Nat Prod Commun. 2012 Jan;7(1):47-50
pubmed: 22428242
Anal Biochem. 1968 Oct 24;25(1):192-205
pubmed: 4973948
Oxid Med Cell Longev. 2009 Nov-Dec;2(5):270-8
pubmed: 20716914
Cancer Res. 1994 Apr 1;54(7 Suppl):1982s-1986s
pubmed: 8137324
Toxicol Res. 2017 Apr;33(2):79-96
pubmed: 28443179
Drug Metab Dispos. 1998 Oct;26(10):989-92
pubmed: 9763404
Biochem Pharmacol. 1997 Feb 21;53(4):531-8
pubmed: 9105404
Cancer Lett. 2004 Apr 30;207(2):157-63
pubmed: 15072824
Anticancer Agents Med Chem. 2012 May;12(4):383-90
pubmed: 22043989
Cancer Lett. 1991 Oct;60(1):15-24
pubmed: 1913623
Biol Chem. 2002 Jun;383(6):907-14
pubmed: 12222680
J Pharm Pharmacol. 2018 Nov;70(11):1553-1560
pubmed: 30159909
Basic Clin Pharmacol Toxicol. 2008 Aug;103(2):137-42
pubmed: 18816296
Mol Cancer Ther. 2005 Feb;4(2):333-42
pubmed: 15713904
Biomed Res Int. 2016;2016:5341081
pubmed: 28105425
J Environ Pathol Toxicol Oncol. 2017;36(1):87-98
pubmed: 28605333
Mutat Res. 1983 May;113(3-4):173-215
pubmed: 6341825